Desmopressin vs GPE

Head-to-head comparison of Desmopressin (1-Deamino-8-D-arginine vasopressin) and GPE (Glycyl-L-prolyl-L-glutamic acid) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyDesmopressinGPE
CategoryCognitive EnhancementCognitive Enhancement
Full Name1-Deamino-8-D-arginine vasopressinGlycyl-L-prolyl-L-glutamic acid
Molecular Weight1069.22 Da301.30 Da
Half-Life1.5-3 hoursminutes
Amino Acids93
Typical Dose10-40 mcg intranasal0.1-10 mg/kg preclinical
RouteIntranasal/OralIntranasal/Intracerebroventricular
Purity≥98%≥98%
Studies Count3525
Research StatusClinicalPre-clinical

Desmopressin Benefits

  • memory consolidation
  • reduced pressor burden
  • recall support
  • short-term learning

GPE Benefits

  • memory consolidation
  • neuroprotection
  • synaptic plasticity
  • learning support

Desmopressin Dosing

intranasal research dosing|10-40 mcg or IU-equivalent studies|single-dose protocols

GPE Dosing

intranasal or ICV research doses|0.1-10 mg/kg preclinical range|repeat daily or intermittent protocols

Desmopressin Side Effects

  • hyponatremia
  • headache
  • nasal irritation

GPE Side Effects

  • limited human safety data
  • short half-life
  • local irritation with nasal delivery

Research Overview

Desmopressin

The literature is mixed, but desmopressin has shown memory-related effects in selected populations and experimental paradigms. Its cognitive effects are usually discussed as a vasopressin-pathway probe rather than a primary nootropic.

GPE

Preclinical studies suggest GPE can reduce neuronal damage and support plasticity-related pathways in the brain. Research interest centers on hippocampal function, which links it to learning and memory paradigms.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Desmopressin stacks with:

arginine-vasopressinnoopeptgpe

GPE stacks with:

davunetidenoopeptarginine-vasopressin
vasopressin-analogmemorypeptidetripeptideneuroprotection